2011 年美国风湿病学会治疗幼年特发性关节炎的建议：关节炎和全身表现治疗药物的起始治疗和安全性监测。
2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.
机构信息
University of Alabama at Birmingham, Birmingham, AL 35233-1711, USA.
出版信息
Arthritis Care Res (Hoboken). 2011 Apr;63(4):465-82. doi: 10.1002/acr.20460.
Abstract
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient’s individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice.
摘要
美国风湿病学会（ACR）制定和/或认可的指南和建议旨在为特定的实践模式提供指导，而不是决定特定患者的治疗方案。ACR 认为，这些指南和建议的遵循是自愿的，最终的决定应根据每个患者的具体情况由医生做出。指南和建议旨在促进有益或理想的结果，但不能保证任何特定的结果。ACR 制定或认可的指南和建议会根据医学知识、技术和实践的发展进行定期修订。
相似文献
1
2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.2011 年美国风湿病学会治疗幼年特发性关节炎的建议：关节炎和全身表现治疗药物的起始治疗和安全性监测。
Arthritis Care Res (Hoboken). 2011 Apr;63(4):465-82. doi: 10.1002/acr.20460.
2
Recommendations for juvenile idiopathic arthritis by the American College of Rheumatology: comment on the article by Beukelman et al.美国风湿病学会关于幼年特发性关节炎的建议：对Beukelman等人文章的评论
Arthritis Care Res (Hoboken). 2011 Sep;63(9):1354-5; author reply 1355-6. doi: 10.1002/acr.20521.
3
2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.2013 年更新的 2011 年美国风湿病学会治疗幼年特发性关节炎的建议：全身型幼年特发性关节炎儿童的药物治疗建议和接受生物制剂治疗儿童的结核筛查。
Arthritis Care Res (Hoboken). 2013 Oct;65(10):1551-63. doi: 10.1002/acr.22087.
4
[Biologics for treatment of juvenile idiopathic arthritis. Consensus statement of the 7th Wörlitzer Expertengespräche 2004 for the German Arbeitsgemeinschaft Kinder- und Jugendrheumatologie].[用于治疗幼年特发性关节炎的生物制剂。2004年第七届沃利策专家会议为德国儿童和青少年风湿病协会达成的共识声明]
Z Rheumatol. 2006 Mar;65(2):152-6, 158. doi: 10.1007/s00393-005-0002-7.
5
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.美国风湿病学会2010年糖皮质激素性骨质疏松症预防和治疗指南
Arthritis Care Res (Hoboken). 2010 Nov;62(11):1515-26. doi: 10.1002/acr.20295. Epub 2010 Jul 26.
6
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis.2021 年美国风湿病学会幼年特发性关节炎治疗指南：寡关节炎、颞下颌关节炎和全身型幼年特发性关节炎的治疗方法。
Arthritis Care Res (Hoboken). 2022 Apr;74(4):521-537. doi: 10.1002/acr.24853. Epub 2022 Mar 1.
7
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.2019 年美国风湿病学会/关节炎基金会青少年特发性关节炎相关葡萄膜炎筛查、监测和治疗指南。
Arthritis Care Res (Hoboken). 2019 Jun;71(6):703-716. doi: 10.1002/acr.23871. Epub 2019 Apr 25.
8
Management of Juvenile Idiopathic Arthritis 2015: A Position Statement from the Pediatric Committee of the Canadian Rheumatology Association.《2015年青少年特发性关节炎的管理：加拿大风湿病协会儿科委员会的立场声明》
J Rheumatol. 2016 Oct;43(10):1773-1776. doi: 10.3899/jrheum.160074.
9
Lack of information in current guidelines regarding systemic corticosteroids in inflammatory diseases.当前指南中缺乏关于炎症性疾病全身用糖皮质激素的信息。
Dermatol Online J. 2014 Mar 17;20(3):doj_21761.
10
[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 3 Clinical symptoms].[德国风湿病学会关于包括贝赫切特病和早期形式的轴性脊柱关节炎的S3指南：3临床症状]
Z Rheumatol. 2014 Sep;73 Suppl 2:28-39. doi: 10.1007/s00393-014-1428-6.
引用本文的文献
1
Literature analysis and implication of biologic therapy for children with non-systemic juvenile idiopathic arthritis in real-world settings.现实环境中生物疗法对非系统性幼年特发性关节炎患儿的文献分析及意义
Intractable Rare Dis Res. 2025 Aug 31;14(3):162-174. doi: 10.5582/irdr.2025.01035.
2
Factors that influence school attendance and participation in children and adolescents with juvenile idiopathic arthritis - a systematic review of the literature.影响幼年特发性关节炎儿童及青少年上学出勤率和参与度的因素——文献系统综述
Pediatr Rheumatol Online J. 2025 May 8;23(1):47. doi: 10.1186/s12969-025-01101-7.
3
The impact of BMI on disease activity and growth outcomes in juvenile idiopathic arthritis.体重指数对幼年特发性关节炎疾病活动及生长结局的影响。
Eur J Pediatr. 2025 Mar 19;184(4):259. doi: 10.1007/s00431-025-06084-x.
4
Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis.用于青少年特发性关节炎的肿瘤坏死因子（TNF）抑制剂
Cochrane Database Syst Rev. 2025 Feb 20;2(2):CD013715. doi: 10.1002/14651858.CD013715.pub2.
5
Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study.静脉注射阿巴西普治疗多关节型幼年特发性关节炎的安全性和有效性：一项全病例上市后监测研究。
Pediatr Rheumatol Online J. 2025 Feb 19;23(1):19. doi: 10.1186/s12969-025-01069-4.
6
Pediatric Society of the African League Against Rheumatism juvenile idiopathic arthritis recommendations for enthesitis-related arthritis and juvenile psoriatic arthritis.非洲抗风湿病联盟儿科学会关于附着点炎相关关节炎和青少年银屑病关节炎的建议。
Clin Rheumatol. 2025 Mar;44(3):901-922. doi: 10.1007/s10067-025-07334-x. Epub 2025 Feb 1.
7
Evaluation of ILAR and PRINTO classifications for juvenile idiopathic arthritis: oligoarticular JIA vs early-onset ANA-positive JIA.幼年特发性关节炎的ILAR和PRINTO分类评估：少关节型幼年特发性关节炎与早发型ANA阳性幼年特发性关节炎
Clin Rheumatol. 2025 Mar;44(3):1307-1316. doi: 10.1007/s10067-025-07340-z. Epub 2025 Jan 30.
8
Treatment of refractory poly articular course juvenile idiopathic arthritis with tofacitinib: Extended experience from Bangladesh.托法替布治疗难治性多关节型幼年特发性关节炎：来自孟加拉国的扩展经验。
PLoS One. 2025 Jan 24;20(1):e0312174. doi: 10.1371/journal.pone.0312174. eCollection 2025.
9
Global research trends in biological therapy for ankylosing spondylitis: A comprehensive visualization and bibliometric study (2004-2023).强直性脊柱炎生物治疗的全球研究趋势：一项全面的可视化和文献计量学研究（2004 - 2023年）
Hum Vaccin Immunother. 2025 Dec;21(1):2445900. doi: 10.1080/21645515.2024.2445900. Epub 2025 Jan 15.
10
Trends in New Use of Disease-Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022.2001年至2022年美国商业保险儿童中用于幼年特发性关节炎的改善病情抗风湿药新使用趋势
Arthritis Rheumatol. 2025 Apr;77(4):468-476. doi: 10.1002/art.43041. Epub 2024 Dec 10.
本文引用的文献
1
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.美国风湿病学会2010年糖皮质激素性骨质疏松症预防和治疗指南
Arthritis Care Res (Hoboken). 2010 Nov;62(11):1515-26. doi: 10.1002/acr.20295. Epub 2010 Jul 26.
2
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.EULAR 推荐的使用合成和生物疾病修饰抗风湿药物治疗类风湿关节炎的建议。
Ann Rheum Dis. 2010 Jun;69(6):964-75. doi: 10.1136/ard.2009.126532. Epub 2010 May 5.
3
Monitoring methotrexate toxicity in juvenile idiopathic arthritis.监测幼年特发性关节炎中甲氨蝶呤的毒性。
J Rheumatol. 2009 Dec;36(12):2813-8. doi: 10.3899/jrheum.090482. Epub 2009 Nov 16.
4
Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents.接受抗肿瘤坏死因子药物治疗的全身型幼年特发性关节炎患者的临床缓解情况。
J Rheumatol. 2009 May;36(5):1078-82. doi: 10.3899/jrheum.090952.
5
Development and validation of a composite disease activity score for juvenile idiopathic arthritis.青少年特发性关节炎综合疾病活动评分的制定与验证
Arthritis Rheum. 2009 May 15;61(5):658-66. doi: 10.1002/art.24516.
6
Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.阿那白滞素治疗全身性幼年特发性关节炎：落基山地区的经验。
J Clin Rheumatol. 2009 Jun;15(4):161-4. doi: 10.1097/RHU.0b013e3181a4f459.
7
Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.治疗时机作为幼年特发性关节炎对甲氨蝶呤反应的一个重要因素。
Arthritis Rheum. 2009 Jan 15;61(1):46-51. doi: 10.1002/art.24087.
8
Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.幼年特发性关节炎患者的抗环瓜氨酸肽抗体
Immunol Invest. 2008;37(8):849-57. doi: 10.1080/08820130802438057.
9
Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: a decision analysis.幼年特发性关节炎中膝关节单关节炎的最佳治疗：一项决策分析。
Arthritis Rheum. 2008 Nov 15;59(11):1580-8. doi: 10.1002/art.24190.
10
Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study.阿那白滞素治疗多关节型幼年类风湿关节炎：一项随机多中心研究的安全性及初步疗效结果
Clin Rheumatol. 2009 Feb;28(2):129-37. doi: 10.1007/s10067-008-0995-9. Epub 2008 Sep 3.
Zotero 插件